Celgene Corporation (Nasdaq: CELG) and Abraxis BioScience (Nasdaq: ABII) jointly announced the signing of a definitive merger ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE